EssilorLuxottica Logo

EssilorLuxottica

ISIN: FR0000121667 | Ticker: EL | LEI: 549300M3VH1A3ER1TB49
Sector: Health CareSub-Industry: Health Care Supplies
Country: France

About EssilorLuxottica

Company Description

EssilorLuxottica, a fully integrated player, is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company brings together the complementary expertise of two industry pioneers, one in advanced lens technologies and the other in the craftsmanship of iconic eyewear, to create a vertically-integrated business that is uniquely positioned to address the world’s evolving vision needs and the global demand of a growing eyewear industry. Founded in 1849, Essilor’s long history is bound to its mission of improving lives by improving sight. This mission has borne major technological advances such as the invention of the organic lens and the progressive lens.

Year founded

2018

Served area

Worldwide

Headcount

180,000

Headquarters

147 Rue de Paris, 94220 Charenton-Le-Pont – France

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 52,318,000,000.00 59,415,000,000.00 60,561,000,000.00
Noncurrent Assets N/A 38,598,000,000.00 50,140,000,000.00 51,920,000,000.00
Property Plant And Equipment N/A 3,348,000,000.00 4,211,000,000.00 4,747,000,000.00
Goodwill N/A 22,658,000,000.00 29,104,000,000.00 30,734,000,000.00
Intangible Assets Other Than Goodwill N/A 10,031,000,000.00 12,599,000,000.00 12,122,000,000.00
Investment Accounted For Using Equity Method N/A 17,000,000.00 91,000,000.00 83,000,000.00
Deferred Tax Assets N/A 418,000,000.00 487,000,000.00 408,000,000.00
Other Noncurrent Assets N/A 374,000,000.00 718,000,000.00 817,000,000.00
Inventories N/A 1,930,000,000.00 2,445,000,000.00 2,789,000,000.00
Current Trade Receivables N/A 2,066,000,000.00 2,355,000,000.00 2,697,000,000.00
Current Tax Assets Current N/A 195,000,000.00 296,000,000.00 259,000,000.00
Cash and cash equivalents 4,836,000,000.00 8,683,000,000.00 3,293,000,000.00 1,960,000,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 13,720,000,000.00 9,193,000,000.00 8,641,000,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 0.00 82,000,000.00 0.00
Other Current Assets N/A 847,000,000.00 804,000,000.00 936,000,000.00
Equity And Liabilities N/A 52,318,000,000.00 59,415,000,000.00 60,561,000,000.00
Equity 35,332,000,000.00 32,798,000,000.00 35,875,000,000.00 38,147,000,000.00
Issued Capital N/A 79,000,000.00 80,000,000.00 81,000,000.00
Retained Earnings Profit Loss For Reporting Period N/A N/A 1,448,000,000.00 2,152,000,000.00
Share Premium N/A 22,012,000,000.00 22,381,000,000.00 23,066,000,000.00
Treasury Shares N/A 201,000,000.00 231,000,000.00 360,000,000.00
Equity Attributable To Owners Of Parent N/A 32,268,000,000.00 35,064,000,000.00 37,455,000,000.00
Noncontrolling Interests N/A 530,000,000.00 811,000,000.00 692,000,000.00
Noncurrent Liabilities N/A 13,349,000,000.00 14,602,000,000.00 13,525,000,000.00
Noncurrent Provisions For Employee Benefits N/A 484,000,000.00 537,000,000.00 431,000,000.00
Other Longterm Provisions N/A 170,000,000.00 243,000,000.00 302,000,000.00
Deferred Tax Liabilities N/A 1,887,000,000.00 2,536,000,000.00 2,377,000,000.00
Other Noncurrent Liabilities N/A 73,000,000.00 143,000,000.00 221,000,000.00
Longterm Borrowings N/A 9,324,000,000.00 8,913,000,000.00 7,858,000,000.00
Other Shortterm Provisions N/A 271,000,000.00 373,000,000.00 283,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 1,864,000,000.00 2,218,000,000.00 2,297,000,000.00
Current Tax Liabilities Current N/A 530,000,000.00 805,000,000.00 711,000,000.00
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 6,171,000,000.00 8,925,000,000.00 8,888,000,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 0.00 13,000,000.00 0.00
Other Current Liabilities N/A 2,346,000,000.00 3,655,000,000.00 3,587,000,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 633,000,000.00 1,036,000,000.00 1,164,000,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 14,429,000,000.00 19,820,000,000.00 24,494,000,000.00
Profit Loss From Operating Activities 452,000,000.00 2,307,000,000.00 3,157,000,000.00
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method 1,000,000.00 3,000,000.00 6,000,000.00
Profit Loss Before Tax 313,000,000.00 2,181,000,000.00 3,032,000,000.00
Income Tax Expense Continuing Operations 164,000,000.00 582,000,000.00 751,000,000.00
Profit Loss From Continuing Operations 149,000,000.00 1,598,000,000.00 2,281,000,000.00
Profit (loss) 149,000,000.00 1,598,000,000.00 2,281,000,000.00
Profit Loss Attributable To Owners Of Parent 85,000,000.00 1,448,000,000.00 2,152,000,000.00
Profit Loss Attributable To Noncontrolling Interests 64,000,000.00 150,000,000.00 128,000,000.00
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 149,000,000.00 1,598,000,000.00 2,281,000,000.00
Adjustments For Income Tax Expense N/A 164,000,000.00 582,000,000.00 751,000,000.00
Adjustments For Provisions N/A 63,000,000.00 38,000,000.00 -51,000,000.00
Adjustments For Sharebased Payments N/A 156,000,000.00 160,000,000.00 191,000,000.00
Other Adjustments For Noncash Items N/A -22,000,000.00 -31,000,000.00 -72,000,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets N/A 6,000,000.00 2,000,000.00 2,000,000.00
Interest Paid Classified As Operating Activities N/A 112,000,000.00 125,000,000.00 125,000,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 356,000,000.00 618,000,000.00 940,000,000.00
Cash Flows From Used In Operating Activities N/A 2,953,000,000.00 4,545,000,000.00 4,783,000,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 133,000,000.00 7,078,000,000.00 965,000,000.00
Cash Flows From Used In Investing Activities N/A -480,000,000.00 -8,060,000,000.00 -2,619,000,000.00
Payments From Changes In Ownership Interests In Subsidiaries N/A 94,000,000.00 67,000,000.00 674,000,000.00
Proceeds From Issuing Shares N/A 36,000,000.00 34,000,000.00 37,000,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 159,000,000.00 317,000,000.00 431,000,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 461,000,000.00 722,000,000.00 955,000,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities N/A -244,000,000.00 18,000,000.00 -507,000,000.00
Cash Flows From Used In Financing Activities N/A 1,498,000,000.00 -2,040,000,000.00 -3,580,000,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 3,970,000,000.00 -5,555,000,000.00 -1,417,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -123,000,000.00 166,000,000.00 83,000,000.00
Cash and cash equivalents 4,836,000,000.00 8,683,000,000.00 3,293,000,000.00 1,960,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
FRA
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
20.12.23 None Other Buy EUR 195,047.16
20.12.23 None Other Buy EUR 19,173.66
20.12.23 None Other Buy EUR 15,035.46
20.12.23 None Other Buy EUR 14,621.64
27.10.23 None Other Buy EUR 504,038.40
02.10.23 None Other Sell EUR 5,835,900.00
02.10.23 None Other Buy EUR 5,835,900.00
02.10.23 None Other Buy EUR 0.00
26.09.23 None Other Buy EUR 162,852.20
21.08.23 None Other Sell EUR 2,534,525.00

Capital markets information

ISIN

FR0000121667

LEI

549300M3VH1A3ER1TB49

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Euronext Paris

Stock Index

CAC40

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.